Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rayos in untreated polymyalgia rheumatica
NCT02702778Phase 2Terminated
- Sponsor
- DINORA
- Start
- Feb 2016
- Primary completion
- Dec 2016
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of prednisone in polymyalgia rheumatica (PMR), sponsored by DINORA. Started Feb 2016; status: terminated.
02
Drugs
prednisone
03
Conditions
polymyalgia rheumatica (PMR)
Beyond the preview
Go deeper on NCT02702778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02702778.